Results 281 to 290 of about 9,406,168 (354)

Coronavirus JHM-Induced Demyelinating Encephalomyelitis in Rats: Influence of Immunity on the Course of Disease

, 1983
Helmut Wege, Rihito Watanabe, Makoto Koga, Volker ter Meulen   +3 more
openalex   +2 more sources

Clinical Utility of Serum Neurofilament Light Chain in Peripheral Neuropathy

Muscle &Nerve, Volume 73, Issue 1, Page 86-92, January 2026.
ABSTRACT Introductions/Aims The clinical utility of serum neurofilament light chain (sNfL) in the evaluation and management of peripheral neuropathy (PN) remains poorly defined. This study aimed to evaluate the utility of sNfL for diagnosing PN, assessing disease activity, and monitoring treatment response using a commercially available assay.
Chafic Karam
wiley   +1 more source

Serum Thyroid-Stimulating Hormone and Anti-Thyroglobulin Antibody Are Independently Associated with Lesions in Spinal Cord in Central Nervous System Demyelinating Diseases

, 2014
Youming Long, Yangbo Zheng, Mengyu Chen, Bin Zhang, Cong Gao, Fulan Shan, Ning Yang, Yongxiang Fan   +7 more
openalex   +2 more sources

Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: A retrospective ultrasound study

Muscle and Nerve, 2014
C. Zaidman, A. Pestronk
semanticscholar   +1 more source

Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis

Neurourology and Urodynamics, Volume 45, Issue 1, Page 187-199, January 2026.
ABSTRACT Aim Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Carlos Ferreira, Paula Soeiro, Sara Fonseca, Zaruhi Arakelyan, João Silva, Carlos Martins Silva, Francisco Cruz, Joana Guimarães, Tiago Antunes Lopes   +8 more
wiley   +1 more source

Impact of a GABA‐Producing Lactococcus lactis on Microbiota and Mycobiota During CNS Inflammatory Demyelination

FASEB BioAdvances, Volume 8, Issue 1, January 2026.
GABA‐producing Lactococcus lactis protects against experimental autoimmune encephalomyelitis (EAE) in a mouse source‐dependent manner. The study focuses on the therapeutic potential of genetically engineered gamma‐aminobutyric acid (GABA)‐overproducing Lactococcus lactis (P8s‐GAD L. lactis) in the EAE model.
Kristina Hill, Alexandra LaFollette, Trevor O. Kirby, Soledad Negrete, Dani Babcock, Kari Felton, Hannah Kohl, Kavita Sharma, Andrea Castillo, Jean‐Baptiste Roullet, K. Michael Gibson, Javier Ochoa‐Repáraz   +11 more
wiley   +1 more source

[An interpretation of consensus statements on diagnostic criteria for multiple sclerosis and demyelinating diseases of the central nervous system in children (2012 version)].

, 2016
Kun Yang, Yucai Chen
openalex   +2 more sources

Melanoma Differentiation-Associated Gene 5 Is Critical for Protection against Theiler's Virus-Induced Demyelinating Disease

Journal of Virology, 2011
Young-Hee Jin, Seung Jae Kim, E. So, Liping Meng, M. Colonna, Byung S. Kim   +5 more
semanticscholar   +1 more source

Downregulation of BST2 Rescues Cochlear Nerve Demyelination in Age‐Related Hearing Loss via Enhancing Schwann Cell Migration

Aging Cell, Volume 25, Issue 1, January 2026.
The illustration indicates that increased BST2 expression in Schwann cells leads to cochlear nerve demyelination, accelerating hearing loss in ARHL. The upregulation of BST2 reduces POU6F1 expression by activating the NF‐κB pathway, which impairs MPZ transcription and Schwann cell migration, ultimately contributing to neural demyelination in ARHL ...
Mengxiao Liu, Qi Li, Huan Cao, Huan Yin, Jianwang Yang, Tao Liu, Jiantao Wang, Lei Zhao, Baoshan Wang   +8 more
wiley   +1 more source

Dysregulation of the endosomal sorting complex III is linked to neurodegeneration in progressive multiple sclerosis

Brain Pathology, Volume 36, Issue 1, January 2026.
This study shows that components of the ESCRT‐III membrane repair machinery, VPS4B and CHMP2A, are dysregulated in progressive MS and are associated with higher neurodegeneration and inflammation. This might lead to improper function of the complex to inhibit the final stages of necroptosis activation and thus impede neuronal cell death.
Carmen Picon, Robertas Aleksynas, Marcelina Wojewska, Francesco de Virgiliis, Doron Merkler, Richard Reynolds   +5 more
wiley   +1 more source